Product Description
Overall, the global diagnostic and interventional guidewire market was valued at $661 million in 2023. This is expected to increase over the forecast period at a CAGR of 5.6% to reach over $969 million.
Throughout this medical market research, we analyzed over 20 diagnostic & interventional guidewire companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for diagnostic & interventional guidewiresextends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Diagnostic & Interventional Guidewire Market Insights
Global Diagnostic & Interventional Guidewire Market Share Insights
Terumo secures its predominant position in the market through the innovative hydrophilic guidewire technology found in its Glidewire® Advantage™ device. This pioneering tool allows simultaneous lesion crossing and interventional device delivery. The Glidewire® product range presents various configurations, all built with a nitinol core to resist kinking and a tungsten jacket for superior radiopacity. The Glidewire® GT boasts a flexible distal end, while the Glidewire® Gold stands out with a gold tip band for enhanced radiopacity, reinforcing Terumo’s stronghold in the hydrophilic guidewire market.
Boston Scientific, benefitting from its distribution of Terumo products between 1991 and 2006, maintains strong customer relationships that have bolstered sales for its SAVION™ and V-14™ ControlWire™ product lines. The company has successfully marketed its guidewires in conjunction with popular peripheral stents and percutaneous transluminal angioplasty (PTA) balloon catheters. The Victory™ guidewires offer versatility with various tip loads ranging from 12 to 30 grams, amplifying their efficacy in tackling resistant lesions.
Cook Medical boasts an extensive collection of guidewires, notably showcasing the Amplatz® Approach®, HiWire®, and Roadrunner® product lines. Among these, the Amplatz® Stiff guidewires stand out due to their distinct stiff-to-flexible transition, enabling intricate maneuvers within challenging vasculature that is hard to access.
Market Segmentation Summary
- Standard Guidewires
- Hydrophilic Guidewires
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
